Treatment of myxedema-associated cardiogenic shock.
Klein
I
I
D006801:Humans; D009230:Myxedema / Q000150:complications*; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D014284:Triiodothyronine / Q000627:therapeutic use*; D016277:Ventricular Function, Left / Q000187:drug effects*
D014284:Triiodothyronine